Robert Benjamin Stein Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Benjamin Stein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Benjamin Stein. Robert Benjamin Stein is Director in Protagenic Therapeutics, Inc.\new ($ATRN) and Chief Scientific Officer in AGENUS INC ($AGEN) and President R&D in AGENUS INC ($AGEN) and EVP, Research and Development in MIMEDX GROUP, INC. ($AYXC.OB).
Latest Insider Trading Transactions of Robert Benjamin Stein
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGEN, AYXC.OB, PTIX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2021 | AYXC.OB | MIMEDX GROUP, INC. | Stein Robert Benjamin | EVP, Research and D ... | Grant | A | 0.00 | 109,235 | 0 | 191,068 | 81.8 K to 191.1 K (+133.49 %) |
| Aug 12 2020 | AYXC.OB | MIMEDX GROUP, INC. | Stein Robert Benjamin | EVP, Research and D ... | Grant | A | 6.11 | 81,833 | 500,000 | 81,833 | 0 to 81.8 K |
| Feb 26 2020 | PTIX | Protagenic Therape ... | Stein Robert Benjamin | Director | Option Exercise | A | 1.75 | 150,000 | 262,500 | 150,000 | |
| Oct 18 2017 | PTIX | Protagenic Therape ... | Stein Robert Benjamin | Director | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
| Jun 21 2016 | ATRN | Protagenic Therape ... | Stein Robert Benjamin | Director | Grant | A | 1.25 | 40,000 | 50,000 | 240,000 | 200 K to 240 K (+20.00 %) |
| Jun 16 2016 | AGEN | AGENUS INC | Stein Robert Benjamin | President R&D | Option Exercise | A | 0.00 | 34,000 | 0 | 34,000 | |
| Jun 16 2016 | AGEN | AGENUS INC | Stein Robert Benjamin | President R&D | Option Exercise | A | 4.16 | 250,000 | 1,040,000 | 250,000 | |
| Apr 28 2016 | AGEN | AGENUS INC | Stein Robert Benjamin | Chief Scientific Of ... | Sell | D | 4.15 | 12,265 | 50,900 | 20,776 | 33 K to 20.8 K (-37.12 %) |
| Apr 28 2016 | AGEN | AGENUS INC | Stein Robert Benjamin | Chief Scientific Of ... | Grant | A | 4.15 | 33,041 | 137,120 | 33,041 | 0 to 33 K |
| Jul 08 2015 | AGEN | AGENUS INC | Stein Robert Benjamin | Chief Scientific Of ... | Option Exercise | A | 5.04 | 18,750 | 94,500 | 18,750 | |
| Feb 17 2015 | AGEN | AGENUS INC | Stein Robert Benjamin | Chief Scientific Of ... | Option Exercise | A | 5.04 | 87,500 | 441,000 | 87,500 | |
| Feb 19 2014 | AGEN | AGENUS INC | Stein Robert Benjamin | Chief Scientific Of ... | Option Exercise | A | 3.00 | 200,000 | 600,000 | 200,000 |
Page: 1